Whats Inside the Kit
Composition and Formulation 2.1 Active Ingredient: Semaglutide Structure and Properties 2.2 Mechanism-Enhancing Modifications (Albumin Binding, Half-Life Extension) 2.3 Available Dosage Forms (Injectable, Oral if applicable) 2.4 Excipients and Inactive Ingredients 2.5 Packaging Types (Pre-filled Pens, Vials, Tablets) 3.1 GLP-1 Receptor Agonism Explained 3.2 Effects on Insulin Secretion and Glucagon Suppression 3.3 Impact on Gastric Emptying and Appetite Regulation 3.4 Central Nervous System Effects on Satiety 3.5 Cardiometabolic Benefits Beyond Glycemic Control 4
Dejgaard TF, Schmidt S, Frandsen CS et al (2020) Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: the Lira Pump triala randomized, double-blinded, placebo-controlled trial
This formula is designed for individuals seeking to maintain cardiovascular health, energy metabolism and antioxidant support, using a balanced nutritional approach
The company's clinical trials reported increases in GLP-1 levels (up to 140% in some participants!), along with reductions in visceral fat (up to 27% in some participants!) and overall body fat (up to 5% in some participants!)